BIOCARTIS US INC

BioCartis US Inc. specializes in the manufacturing, maintenance, and support of advanced in vitro diagnostic systems and precision laboratory instruments for clinical and research applications. The company provides critical reagents and consumables for molecular diagnostics, particularly in oncology, and delivers comprehensive service agreements for its Idylla™ platform—ensuring continuous operational integrity of automated, real-time PCR-based analytical systems. Their technical expertise lies in integrating diagnostic reagents with proprietary instrumentation to enable rapid, sample-to-answer molecular testing in clinical environments, with a focus on precision medicine workflows and laboratory automation. Key differentiators include deep domain knowledge in assay development for cancer biomarkers and end-to-end support for diagnostic equipment deployed in high-throughput, regulated settings. The Department of Veterans Affairs is the primary federal partner, consistently engaging BioCartis for diagnostic reagent supply, instrument procurement, and ongoing service and maintenance of molecular diagnostic platforms. This sustained relationship reflects a trusted provider role in supporting VA’s clinical laboratories with reliable, FDA-cleared diagnostic solutions for patient care and research initiatives. BioCartis operates primarily within the in vitro diagnostic substance manufacturing, analytical laboratory instrument manufacturing, and electronic equipment repair and maintenance sectors. These NAICS codes reflect a focused market position as a vertical integrator of diagnostic systems—combining proprietary reagents, hardware, and service to deliver end-to-end molecular testing solutions for clinical labs. BioCartis US Inc. is structured as a 2L entity with its headquarters in Itasca, Illinois. While no federal certifications are currently listed, the company’s consistent performance with the VA underscores its reliability in meeting stringent government procurement and regulatory standards for medical diagnostic technologies. Its geographic presence supports federal healthcare delivery through direct supply and service networks aligned with VA medical center requirements.